Disease | breast cancer |
Symptom | C0948265|metabolic syndrome |
Sentences | 15 |
PubMedID- 21249376 | Objective: this study was aimed to assess the prevalence of metabolic syndrome in patients with breast cancer and the independent effect of metabolic syndrome on breast cancer risk. |
PubMedID- 26030767 | Results: presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (hr 1.52, 95%ci 1.14-2.02). |
PubMedID- 21964613 | A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor. |
PubMedID- 25979299 | Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. |
PubMedID- 19851862 | The association of metabolic syndrome with triple-negative breast cancer. |
PubMedID- 21890443 | metabolic syndrome and incidence of liver and breast cancers in japan. |
PubMedID- 22740197 | Several studies have examined the association of the individual components of the metabolic syndrome with breast cancer. |
PubMedID- 26175188 | Adherence to wcrf/aicr cancer prevention recommendations and metabolic syndrome in breast cancer patients. |
PubMedID- 25653879 | metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis. |
PubMedID- 24319454 | Due to a higher prevalence of metabolic syndrome in breast cancer survivors, lifestyle interventions are needed to prevent chronic diseases associated with obesity. |
PubMedID- 25979298 | Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. |
PubMedID- 24344007 | The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients. |
PubMedID- 23050155 | breast cancer patients with metabolic syndrome undergoing chemotherapy were found to have an overall poor response to treatment and those patients who specifically had high blood glucose levels were noted to have increased rates of disease progression 2. |
PubMedID- 25083463 | metabolic syndrome in breast cancer. |
PubMedID- 25233884 | Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. |
Page: 1